Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H15Cl3N2OS.HNO3 |
Molecular Weight | 500.783 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O[N+]([O-])=O.ClC1=CC(Cl)=C(C=C1)[C@H](CN2C=CN=C2)OCC3=CSC4=C3C=CC=C4Cl
InChI
InChIKey=HAAITRDZHUANGT-FYZYNONXSA-N
InChI=1S/C20H15Cl3N2OS.HNO3/c21-14-4-5-16(18(23)8-14)19(9-25-7-6-24-12-25)26-10-13-11-27-20-15(13)2-1-3-17(20)22;2-1(3)4/h1-8,11-12,19H,9-10H2;(H,2,3,4)/t19-;/m0./s1
Molecular Formula | HNO3 |
Molecular Weight | 63.0128 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C20H15Cl3N2OS |
Molecular Weight | 437.77 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: description was created based on several sources, including:
http://www.rxlist.com/ertaczo-drug.htm
https://www.drugs.com/mtm/sertaconazole-topical.html
http://www.wikidoc.org/index.php/Sertaconazole
Curator's Comment: description was created based on several sources, including:
http://www.rxlist.com/ertaczo-drug.htm
https://www.drugs.com/mtm/sertaconazole-topical.html
http://www.wikidoc.org/index.php/Sertaconazole
Sertaconazole is a azole antifungal that is FDA approved for the treatment of interdigital tinea pedis in immunocompetent patients 12 years of age and older, caused by: Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum. Sertaconazole interacts with 14-α demethylase, a cytochrome P-450 enzyme necessary to convert lanosterol to ergosterol. As ergosterol is an essential component of the fungal cell membrane, inhibition of its synthesis results in increased cellular permeability causing leakage of cellular contents. Common adverse reactions include contact dermatitis, dry skin, burning skin and application site skin tenderness.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1780 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | ERTACZO Approved UseERTACZO® (sertaconazole nitrate) Cream, 2%, is indicated for the topical treatment of interdigital tinea pedis in immunocompetent patients 12 years of age and older, caused by: Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum (see CLINICAL STUDIES Section). Launch Date2003 |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1.79 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/19889586 |
300 mg single, vaginal dose: 300 mg route of administration: Vaginal experiment type: SINGLE co-administered: |
SERTACONAZOLE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE food status: UNKNOWN |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
43.31 ng × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/19889586 |
300 mg single, vaginal dose: 300 mg route of administration: Vaginal experiment type: SINGLE co-administered: |
SERTACONAZOLE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
20.25 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/19889586 |
300 mg single, vaginal dose: 300 mg route of administration: Vaginal experiment type: SINGLE co-administered: |
SERTACONAZOLE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE food status: UNKNOWN |
Funbound
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1% |
SERTACONAZOLE plasma | Homo sapiens population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN |
Sample Use Guides
Cream should be applied to the affected and immediate surrounding area(s) twice daily for 4 weeks.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9395851
MIC for Candida parapsilosis (0.26 mg/l) demonstrated a higher activity of sertaconazole against this species, in contrast to Candida tropicalis (MIC 1.49 mg/l). Against dermatophytes, MIC for sertaconazole was MIC 0.41 mg/l and against Cryptococcus neoformans yeasts - arithmetic mean MIC 1.24 mg/l.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:32:19 GMT 2023
by
admin
on
Sat Dec 16 11:32:19 GMT 2023
|
Record UNII |
DXL8FD2HFT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DXL8FD2HFT
Created by
admin on Sat Dec 16 11:32:19 GMT 2023 , Edited by admin on Sat Dec 16 11:32:19 GMT 2023
|
PRIMARY | |||
|
583057-49-2
Created by
admin on Sat Dec 16 11:32:19 GMT 2023 , Edited by admin on Sat Dec 16 11:32:19 GMT 2023
|
PRIMARY | |||
|
300000045507
Created by
admin on Sat Dec 16 11:32:19 GMT 2023 , Edited by admin on Sat Dec 16 11:32:19 GMT 2023
|
PRIMARY | |||
|
83692
Created by
admin on Sat Dec 16 11:32:19 GMT 2023 , Edited by admin on Sat Dec 16 11:32:19 GMT 2023
|
PRIMARY | |||
|
9806019
Created by
admin on Sat Dec 16 11:32:19 GMT 2023 , Edited by admin on Sat Dec 16 11:32:19 GMT 2023
|
PRIMARY |